Arterial Insufficiencies: Central Retinal Artery... (2025 study) Skip to main content
Clinical Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2025

Arterial Insufficiencies: Central Retinal Artery Occlusion.

Murphy-Lavoie H, Butler F, Hagan C, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a review of central retinal artery occlusion (CRAO), a sudden blockage of the artery that supplies the retina, and of the treatments tried for it.

What They Found

This review describes CRAO as a relatively rare emergency of the eye that causes sudden, painless vision loss. The abstract says the vision loss is usually dramatic and permanent, and that the outlook for visual recovery is poor. People at particular risk include those with giant cell arteritis, atherosclerosis, and thromboembolic disease. The abstract says many treatments have been tried over the last one hundred years with little to no success, with the exception of hyperbaric oxygen therapy (HBO₂). It gives no numbers, trial results, pressures, or session counts.

What This Means for Canadian Patients

The abstract describes CRAO as an emergency with a poor prognosis for vision. It names hyperbaric oxygen therapy as the one exception among treatments that have had little to no success. It does not say how well HBO₂ works, who should get it, or when treatment should start, so it cannot guide a personal treatment decision. Anyone with sudden vision loss should seek emergency care.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract is a short overview that reports no patient numbers, outcome data, or comparison between treatments, so it does not show how large any benefit of HBO₂ is.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Ocular / Retinal
Source Pubmed
PubMed ID 40819361
Year Published 2025
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Humans; Retinal Artery Occlusion; Hyperbaric Oxygenation; Risk Factors; Giant Cell Arteritis

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology